Top Markets
Coin of the day
Entia Biosciences, Inc. Entia Biosciences, Inc.

Entia Biosciences, Inc.

ERGO
주식 순위 #41967
Entia Biosciences, Inc. engages in the development, production, and... Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
주가
$0.0002
마지막 동기화: 2026-08-11
시가총액
$6.73K
변동 (1일)
0.00%
변동 (1년)
100.00%
국가
US
거래 Entia Biosciences, Inc. (ERGO)

카테고리

Entia Biosciences, Inc. (ERGO)의 배당 수익률 기록
Entia Biosciences, Inc. (주식 심볼: ERGO)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
Entia Biosciences, Inc. (ERGO)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)